Telangana: DCA Cracks Down On Illegal Sale Of Medicines Disguised As Food Products

Hyderabad: Drug inspectors from TS Drugs Control Administration (TSDCA) detected manufacturing of medicines in the guise of ‘food products/ nutraceuticals’ and being sold illegally to the medical shops.

The seized medicines Glucosamine, Methyl sulfonyl methane and Diacerein Tablet, Pregabalin and Methylcobalamin Capsules were being manufactured falsely under a food license at SL Health Care at IDA Prashanthi Nagar, Kukatpally and Medchal-Malkajgiri districts.

During the raid, DCA officials found the firm illegally manufactured and sold two products ORTHO- D (Glucosamine 750 mg, Methyl Sulfonyl Methane 250mg and Diacerin 50 mg Tablet ) & Pregavit-M (Pregabalin 75 mg & Methylcobalamin 750 mcg Capsules) falsely claiming them as food products/nutraceuticals.

ORTHO-D was sold to Balaji Pharma, Narsaraopet, and Pregavit-M to Unity Drugs, Vaddera Bazar, Narsaraopet as per the sales invoices of total worth Rs. 2.90 lakh.

Glucosamine 750 mg, Methyl Sulfonyl Methane 250 mg and Diacerin 50 mg Tablet was approved as drug to treat Osteoarthritis and the product Pregabalin 75 mg and Methylcobalamin 750 mcg Capsules to treat Peripheral Neuropathy in adult patients.

The drugs which are falsely manufactured and sold under a food license are not manufactured in accordance with Good Manufacturing Practices (GMPs) and also fail to meet the quality standards prescribed in Indian Pharmacopoeia (IP) and such products may have serious implications on patient’s health. Manufacturing and selling of ‘drugs’ without a valid ‘drug licence’ is punishable under Drugs and Cosmetics Act, with an imprisonment up to five years, DG, DCA, VB Kamalasan Reddy said.

Related Posts

  • Pharma
  • July 15, 2025
  • 117 views
Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharmaceutical Industries Ltd has announced that it has entered into a settlement and license agreement with Incyte Corporation regarding litigation related to LEQSELVI (deuruxolitinib). “Under the terms of agreement,…

  • Pharma
  • July 15, 2025
  • 142 views
Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Aurobindo Pharma on Tuesday said it will manufacture and supply the long-acting injectable HIV treatment cabotegravir across 133 countries. The Hyderabad-based drugmaker has been selected as one of the generic…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Famous Vaidyaratnam Ayurveda Clinic in Delhi is now more Accessible to Patients

Famous Vaidyaratnam  Ayurveda  Clinic in Delhi is now more Accessible to Patients

Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR

Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR